Naringenin Inhibits Adipogenesis and Reduces Insulin Sensitivity and Adiponectin Expression in Adipocytes
Open Access
- 1 January 2013
- journal article
- research article
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2013, 1-10
- https://doi.org/10.1155/2013/549750
Abstract
Adipose tissue development and function are widely studied to examine the relationship between obesity and the metabolic syndrome. It is well documented that the inability of adipose tissue to properly increase its lipid storage capacity during the obese state can lead to metabolic dysfunction. In a blind screen of 425 botanicals, we identified naringenin as an inhibitor of adipocyte differentiation. Naringenin is one of the most abundant citrus flavonoids, and recent studies have demonstrated antihyperlipidemic capabilities. These studies have largely focused on the effects of naringenin on the liver. Our biochemical studies clearly demonstrate that naringenin inhibits adipogenesis and impairs mature fat cell function. Naringenin specifically inhibited adipogenesis in a dose-dependent fashion as judged by examining lipid accumulation and induction of adipocyte marker protein expression. In mature 3T3-L1 adipocytes, naringenin reduced the ability of insulin to induce IRS-1 tyrosine phosphorylation and substantially inhibited insulin-stimulated glucose uptake in a dose-dependent manner and over a time frame of 1.5 to 24 hours. Exposure to naringenin also inhibited adiponectin protein expression in mature murine and human adipocytes. Our studies have revealed that naringenin may have a negative impact on adipocyte-related diseases by limiting differentiation of preadipocytes, by significantly inducing insulin resistance, and by decreasing adiponectin expression in mature fat cells.Keywords
Funding Information
- National Center for Complementary and Alternative Medicine (2P50AT002776-06)
This publication has 47 references indexed in Scilit:
- New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern TherapeuticsEvidence-Based Complementary and Alternative Medicine, 2013
- Adiponectin in insulin resistance: lessons from translational researchThe American Journal of Clinical Nutrition, 2010
- Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin ResistanceDiabetes, 2009
- Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VIMolecular and Cellular Biology, 2009
- Naringenin and hesperetin, two flavonoids derived from Citrus aurantium up‐regulate transcription of adiponectinPhytotherapy Research, 2008
- Obesity-associated improvements in metabolic profile through expansion of adipose tissueJCI Insight, 2007
- Interactions of the Flavonoid Naringenin in the Gastrointestinal Tract and the Influence of GlycosylationBiochemical and Biophysical Research Communications, 1999
- Phosphoinositide 3-Kinase Is Required for Insulin-Induced but Not for Growth Hormone- or Hyperosmolarity-Induced Glucose Uptake in 3T3-L1 AdipocytesMolecular Endocrinology, 1997
- Overexpression of a Constitutively Active Form of Phosphatidylinositol 3-Kinase Is Sufficient to Promote Glut 4 Translocation in AdipocytesOnline Journal of Public Health Informatics, 1996
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970